Clayton joins Alcresta
This article was originally published in Scrip
Dr Russell Clayton has joined Alcresta, a specialty pharma company focused on enzyme-based products for GI disorders and rare diseases, as chief medical officer. Prior to Alcresta, Dr Clayton held positions of increasing responsibility at Discovery Laboratories, most recently as senior vice president of R&D. Previous employers also include Merck & Co.